| As of Wednesday, November 25th: |
LATEST EARNINGS RESULTS
- Bankruptcies Jump, Hitting Highest Level in Four Years
- AIG, Ex-CEO Greenberg Reach Pact to Settle Disputes
- Bank of America CEO Search May Extend Into 2010
- Steepest Black Friday Discounts, Revealed
- 'Cancer of Fraud' Permeates Health Care System: Critics
- US Mint to Suspend American Eagle Gold 1-Ounce Coins
- Judge Erases Couple's $525,000 Mortgage Payment
- Where Do Pardoned Turkeys Go?
- For Many in US, It Will Be a Scaled-Down Holiday Season
- 4 Thanksgiving Week Buys For Your Portfolio: Market Pros
- There's a 'Great Chance' For a Double-Dip Recession: Strategist
- Revenge of the Gangsta Nerds
- Will TCU See The "Flutie Effect?"
- Retail Earnings and Sales to Improve in Q4: Analyst
- Consumers Catching the Holiday Spirit
- It's Beginning To Look A Lot More Riskless
- Crescenzi: Claims Level Suggests End to Job Losses
- Hedge Funds Take Early Lead in Warren Buffett's 'Big Bet'
MOST SHARED
- The Executive Job Search
- S&P Stocks Trading at New 52-Week Highs
- Judge Erases Couple's $525,000 Mortgage Payment
- Where Do Pardoned Turkeys Go?
- Activision Prepares to Double Dip on ‘Modern Warfare 2’
- US Mint to Suspend American Eagle Gold 1-Ounce Coins
- Salvation Army's Kettles Now Credit Card-Ready
- Foreign Demand Boosts US 7-Year Treasury Sale
- Black Friday: Can Banks Tap the Frenzy, Too?
- Oil Friday
Text Size 
Boston Scientific quarterly earnings fell 15 percent on declining sales of its drug-eluting stents and charges for acquisitions, divestitures and restructuring.
 |
Click for more earnings info |
Second-quarter net income was $98 million, or 7 cents a share, compared with net income of $115 million, or 8 cents a share, a year ago.
Excluding special items, Boston Scientific [BSX
Loading...
()
] said its second- quarter earnings were 20 cents a share.
On that basis, analysts on average had forecast a profit of 18 cents a share, according to Reuters Estimates.
Overall net sales in the second quarter fell about 2 percent to $2.02 billion, compared with $2.07 billion in the year-ago quarter.
The Natick, Massachusetts-based company said worldwide sales of its drug-releasing heart stents declined to $382 million in the second quarter from $437 million a year ago.
U.S. sales of drug-eluting stents were $175 million, down from $249 million.
Stents are small wire mesh tubes inserted into coronary arteries to prop them open after they have been cleared of blockages.
Worldwide sales of cardiac rhythm management devices rose to $578 million, including $420 million in sales of implantable cardioverter defibrillators, which correct abnormal heart rhythms.
CRM sales in last year's quarter were $524 million, including ICD sales of $377 million.
Boston Scientific forecast overall third-quarter sales of between $1.95 billion and $2.06 billion and income, excluding special items, of between 14 cents and 19 cents a share.
It estimated third-quarter net earnings would be between 18 cents and 23 cents a share.
Print
Email
- TiVo Reports Quarterly Loss but Matches Forecasts
TiVo announced a quarterly loss that matched analysts' forecasts, but its sales topped expectations.
- Hewlett-Packard Profit Rises, Matches Guidance
Hewlett-Packard said a strong performance in China and improved profit margins in its services business helped drive quarterly earnings 14 percent higher.
- Analog Devices Results Beat Expectations; Shares Rise
Analog Devices reported a quarterly profit that fell from a year ago but topped Wall Street's expectations, sending shares higher in extended trading.
- TiVo Reports Quarterly Loss but Matches Forecasts
- Tyson Food Profit Beats Estimates
Tyson Foods posted higher-than-expected quarterly results on Monday on strength in its beef, pork and prepared foods businesses, which it expects to continue in its new fiscal year.
- Tyson Food Profit Beats Estimates
- Horton Results Miss Estimates, Shares Drop
- Dell Shares Smacked as Earnings, Sales Miss Forecasts
- Gap Reports Earnings in Line With Forecasts
- Intuit Posts Narrower-Than-Expected Loss
- Sears Posts Second Consecutive Quarterly Loss
- BJ's Wholesale Profit Falls, Hurt by Falling Food Prices
- Salesforce Profit Beats Forecasts, but Shares Fall
- Autodesk Shares Fall on Disappointing Outlook
- Home Depot Profit Beats; Says Markets Under Pressure
- Target Third Quarter Profit Up, Cautious on Fourth
- Weak US Housing Market Drags on Lowe's Profit
- JC Penney Profit Falls, but Shares Up on Forecast
- Disney Profit, Sales Top Forecasts; Shares Jump
- Nordstrom Earnings Miss Forecasts; Shares Take Hit
- Wal-Mart Holiday Forecast Light, Profit Beats
Data is a real-time snapshot *Data is delayed at least 15 minutes